INOVIQ Ltd (ASX:IIQ)
Australia · Delayed Price · Currency is AUD 0.3400
-0.0100 (-2.86%)
At close: Feb 4, 2026
INOVIQ Revenue
In the fiscal year ending June 30, 2025, INOVIQ had annual revenue of 1.82M AUD with 16.25% growth. INOVIQ had revenue of 986.88K in the half year ending June 30, 2025, a decrease of -28.84%.
Revenue
1.82M
Revenue Growth
+16.25%
P/S Ratio
26.37
Revenue / Employee
121.02K
Employees
15
Market Cap
47.86M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.82M | 253.75K | 16.25% |
| Jun 30, 2024 | 1.56M | 10.36K | 0.67% |
| Jun 30, 2023 | 1.55M | -446.01K | -22.33% |
| Jun 30, 2022 | 2.00M | 726.44K | 57.16% |
| Jun 30, 2021 | 1.27M | 735.67K | 137.48% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Healius | 1.34B |
| Australian Clinical Labs | 741.27M |
| Integral Diagnostics | 627.22M |
| Monash IVF Group | 271.92M |
| Genetic Signatures | 19.75M |
| Microba Life Sciences | 15.67M |
| Cryosite | 14.12M |
| Genetic Technologies | 9.17M |